33
Active Trials
12
Phase 1
10
Phase 2
12
Phase 3
15
Therapeutic Areas
Portfolio Concentration: 55% of active trials in Oncology
Oncology
18 active / 110 total
Solid Tumor (Advanced)
7 active
1 Ph3
42 total since 2015
Prostate Cancer
7 active
1 Ph3
15 total since 2015
NSCLC
2 active
1 Ph3
10 total since 2015
Hepatocellular Carcinoma
1 active
5 total since 2015
Breast Cancer
1 active
1 Ph3
1 total since 2015
Non-Hodgkin Lymphoma
0 active
9 total since 2015
Neuroendocrine Tumors
0 active
8 total since 2015
Hematologic Malignancies
0 active
3 total since 2015
Colorectal Cancer
0 active
2 total since 2015
Head and Neck Cancer
0 active
2 total since 2015
Ovarian Cancer
0 active
2 total since 2015
Mesothelioma
0 active
2 total since 2015
Multiple Myeloma
0 active
2 total since 2015
ALL
0 active
2 total since 2015
Bladder Cancer
0 active
1 total since 2015
Melanoma
0 active
1 total since 2015
Sarcoma
0 active
1 total since 2015
Hodgkin Lymphoma
0 active
1 total since 2015
Pancreatic Cancer
0 active
1 total since 2015
Cardiovascular
5 active / 51 total
Heart Failure
2 active
2 Ph3
15 total since 2015
Hypertension
1 active
1 Ph3
9 total since 2015
Coronary Artery Disease
1 active
4 total since 2015
Hypertrophic Cardiomyopathy
1 active
1 Ph3
1 total since 2015
Myocardial Infarction
0 active
12 total since 2015
Stroke
0 active
4 total since 2015
Atrial Fibrillation
0 active
4 total since 2015
Thrombosis
0 active
2 total since 2015
Renal
3 active / 21 total
Immunology
2 active / 47 total
Rare Disease
2 active / 13 total
Women's Health
1 active / 29 total
Metabolic
1 active / 15 total
Infectious Disease
1 active / 4 total
CNS
0 active / 20 total
Urology
0 active / 18 total
Pain
0 active / 15 total
Ophthalmology
0 active / 7 total
Musculoskeletal
0 active / 2 total
Gastrointestinal
0 active / 2 total
Respiratory
0 active / 2 total
Click an indication to see competitive landscape (all sponsors in that indication).
Data: ClinicalTrials.gov (2015+)